Hui Wang

Hui Wang

Director/Board Member bij VIVA BIOTECH HOLDINGS

Vermogen: 27 M $ op 31-03-2024

52 jaar
Health Technology
Finance
Consumer Services

Profiel

Hui Wang has founded Jiangsu Highlight Equity Investment Management Co. Ltd.
in 2014, where he holds the title of Founding Partner.
He is currently the Chief Executive Officer at Highlight Capital Fund since 2014.
Mr. Wang is also a Director at Suzhou Kintor Pharmaceuticals, Inc., a Non-Executive Director at Viva Biotech Holdings starting in 2024, a Director at Biotheus, Inc., a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
since 2020, and a Director at WinnTi Medical Technology (Shanghai) Co., Ltd.
Mr. Wang previously served as a Senior Partner at CDH Venture Partners LP starting in 2009.
He held the position of Vice Chairman at Juva (Tianjin) Medical Technology Co., Ltd.
and Chairman-Supervisory Board at Chengdu Angel Healthcare Holding Co., Ltd.
Mr. Wang was also a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
from 2015 to 2018 and a General Partner at CDH Investments from 2009 to 2014.
He has also worked as a Principal at Becton, Dickinson & Co. Mr. Wang received a graduate degree from New York University in 1998, an undergraduate degree from the University of Science & Technology of China in 1996, and an MBA from London Business School in 2007.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
29-04-2024 22 180 948 ( 6.83% ) 27 M $ 31-03-2024

Actieve functies van Hui Wang

BedrijvenFunctieBegin
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Director/Board Member 28-12-2020
VIVA BIOTECH HOLDINGS Director/Board Member 18-01-2024
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01-01-2009
Founder 01-01-2014
Chief Executive Officer 01-01-2014
Director/Board Member -
Alle actieve functies van Hui Wang

Eerdere bekende functies van Hui Wang

BedrijvenFunctieEinde
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Director/Board Member 01-03-2018
░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ ░░░░░░░░ -
Ervaring van Hui Wang in detail bekijken

Opleiding van Hui Wang

New York University Graduate Degree
University of Science & Technology of China Undergraduate Degree
London Business School Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Hui Wang in detail bekijken

Connecties

100 +

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
BECTON, DICKINSON AND COMPANY

Health Technology

VIVA BIOTECH HOLDINGS

Health Technology

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Health Technology

Bedrijven in privébezit9

Finance

Finance

Finance

Finance

Finance

Distribution Services

Health Technology

Health Technology

Health Technology

Zie bedrijfsconnecties